Hodgkin's disease in the elderly: Improved treatment outcome with a doxorubicin-containing regimen

Journal of Clinical Oncology

Volumn 20, Issue 4, 2002, Pages 1087-1093

  Weekes, Colin D ^a   Vose, Julie M ^a   Lynch, Jim C ^a   Weisenburger, Dennis D ^a   Bierman, Philip J ^a   Greiner, Timothy ^a   Bociek, Gregory ^a   Enke, Charles ^a   Bast, Martin ^a   Chan, Wing C ^a   Armitage, James O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHLORAMBUCIL; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE; PROCARBAZINE; RISK FACTORS; TREATMENT OUTCOME; VINBLASTINE;

EID: 0037083559     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.4.1087     Document Type: Article

References (24)

1. Epidemiological evidence on the nature of Hodgkin's disease
2. A prognostic score for advanced Hodgkin's disease: International prognostic factors project on advanced Hodgkin's disease
3. Survival in Hodgkin's disease by stage and age
4. Survival of the older patient compared with the younger patient with Hodgkin's disease: Influence of histologic type, staging, and treatment
5. Prognostic factors in Hodgkin's disease with special reference to age
6. Hodgkin's disease and age
7. Hodgkin disease in the elderly: A registry-based analysis
8. Outcome of Hodgkin's disease in elderly patients
9. Hodgkin's disease in patients over sixty years old
10. Factors affecting relapse following chemotherapy for Hodgkin's disease
11. The prognosis of Hodgkin's disease in older adults
12. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
13. Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease
14. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
15. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
16. Nonparametric estimation from incomplete observations
17. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples
18. Regression models and life-tables
19. The prognostic significance of age in patients with advanced Hodgkin's disease
20. Hodgkin's disease in the elderly: A series of 30 patients aged older than 70 years
21. Hodgkin disease in patients 60 years of age or older: Histologic and clinical features of advanced-stage disease - The cancer and leukemia group B
22. Clinical data and therapeutic approach in elderly patients with Hodgkin's disease
23. Radiation therapy in the management of early stage Hodgkin's disease presenting in later life